The Thermodynamic Cold-Stop is a set of skids, manifolds and methods that arrest a process stream rapidly and without heat. Instructional Biology supplies it as a retrofit, so it is added to process equipment a manufacturer already runs.

Thermodynamic Cold-Stop, revenue stream 03 of 10: on the seven-stage pipeline (Discovery, Development, Testing, Prototype, Ready for Demo, IND if required, Sales) it is at Development. Protected by: Thermodynamic Cold-Stop. What it is: Supplied as a retrofit: skids, manifolds and methods. Markets its segments address: Process chillers, USD 7.0 bn (2025), 4.5% CAGR.
Thermodynamic Cold-Stop at a glance: its stage, the segments that protect it and the markets they address, as of October 29, 2026.

Where It Stands

The Thermodynamic Cold-Stop is at Development, the second of the seven stages on Our Pipeline: Discovery, Development, Testing, Prototype, Ready for Demo, IND (if required) and Sales.

Why Heat Is the Enemy

A protein's biological function depends on its three-dimensional fold. That fold can be disrupted by heat, by extreme pH or by mechanical shear long before any covalent bond in the molecule breaks: the amino-acid sequence survives, and the shape that made it work does not. Why Does Heat Denature Proteins? explains the chemistry in plain language.

Its Role in MHFBP

In the Markosian High-Fidelity Bio-Processing Protocol (MHFBP), the Thermodynamic Cold-Stop is the thermal guardrail. It engages throughout isolation so the molecules being processed never experience the heat that would unravel their folded shape. Every safety stop runs in hardware on its own, so if ASAP ever goes silent, the process stops safely. The Cold-Stop works alongside our Bioreactor Retrofits.

The Segment That Protects It

The Thermodynamic Cold-Stop is protected by its own segment of our IP portfolio. It is claimed together with MHFBP in U.S. Patent Application No. 19/793,487 (claim 1). The claims are pending and have not been examined.

The Market Behind Its Segment

Each segment of our IP portfolio addresses a market that independent research firms already measure. The table gives that market's latest published size, its forecast and its compound annual growth rate (CAGR), from the same sources as Ten Revenue Streams.

Market and segmentSizeForecastCAGR
Process chillers [1]
Thermodynamic Cold-Stop
USD 7.0 bn (2025)USD 11.3 bn by 20364.5%

These are estimates of whole markets, not Instructional Biology revenue or forecasts.

For partnership or licensing conversations about Thermodynamic Cold-Stop, see Partnerships and Licensing.

Sources

  1. Fact.MR, process chillers market. factmr.com
This page describes a revenue stream and technology under development, in general terms, for a public and non-confidential audience. It is forward-looking, does not disclose proprietary process parameters, and is not a claim that any Instructional Biology product treats, cures or prevents any disease. Market figures are third-party estimates. Nothing on this page is medical advice.
← Back to Ten Revenue Streams